Literature DB >> 25313082

Characterization of HPV and host genome interactions in primary head and neck cancers.

Michael Parfenov1, Chandra Sekhar Pedamallu2, Nils Gehlenborg3, Samuel S Freeman4, Ludmila Danilova5, Christopher A Bristow6, Semin Lee7, Angela G Hadjipanayis1, Elena V Ivanova8, Matthew D Wilkerson9, Alexei Protopopov6, Lixing Yang7, Sahil Seth6, Xingzhi Song6, Jiabin Tang6, Xiaojia Ren1, Jianhua Zhang6, Angeliki Pantazi1, Netty Santoso1, Andrew W Xu7, Harshad Mahadeshwar6, David A Wheeler10, Robert I Haddad11, Joonil Jung4, Akinyemi I Ojesina2, Natalia Issaeva12, Wendell G Yarbrough12, D Neil Hayes13, Jennifer R Grandis14, Adel K El-Naggar15, Matthew Meyerson16, Peter J Park7, Lynda Chin17, J G Seidman18, Peter S Hammerman19, Raju Kucherlapati20.   

Abstract

Previous studies have established that a subset of head and neck tumors contains human papillomavirus (HPV) sequences and that HPV-driven head and neck cancers display distinct biological and clinical features. HPV is known to drive cancer by the actions of the E6 and E7 oncoproteins, but the molecular architecture of HPV infection and its interaction with the host genome in head and neck cancers have not been comprehensively described. We profiled a cohort of 279 head and neck cancers with next generation RNA and DNA sequencing and show that 35 (12.5%) tumors displayed evidence of high-risk HPV types 16, 33, or 35. Twenty-five cases had integration of the viral genome into one or more locations in the human genome with statistical enrichment for genic regions. Integrations had a marked impact on the human genome and were associated with alterations in DNA copy number, mRNA transcript abundance and splicing, and both inter- and intrachromosomal rearrangements. Many of these events involved genes with documented roles in cancer. Cancers with integrated vs. nonintegrated HPV displayed different patterns of DNA methylation and both human and viral gene expressions. Together, these data provide insight into the mechanisms by which HPV interacts with the human genome beyond expression of viral oncoproteins and suggest that specific integration events are an integral component of viral oncogenesis.

Entities:  

Keywords:  cancer; genome rearrangement; head and neck; integration sites; papilloma virus

Mesh:

Year:  2014        PMID: 25313082      PMCID: PMC4217452          DOI: 10.1073/pnas.1416074111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma.

Authors:  Xavier Frigola; Brant A Inman; Christine M Lohse; Christopher J Krco; John C Cheville; R Houston Thompson; Bradley Leibovich; Michael L Blute; Haidong Dong; Eugene D Kwon
Journal:  Clin Cancer Res       Date:  2011-02-25       Impact factor: 12.531

2.  MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors.

Authors:  M Peter; C Rosty; J Couturier; F Radvanyi; H Teshima; X Sastre-Garau
Journal:  Oncogene       Date:  2006-05-08       Impact factor: 9.867

3.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes.

Authors:  Irene Kraus; Corina Driesch; Svetlana Vinokurova; Eivind Hovig; Achim Schneider; Magnus von Knebel Doeberitz; Matthias Dürst
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

5.  Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.

Authors:  Vivian W Y Lui; Matthew L Hedberg; Hua Li; Bhavana S Vangara; Kelsey Pendleton; Yan Zeng; Yiling Lu; Qiuhong Zhang; Yu Du; Breean R Gilbert; Maria Freilino; Sam Sauerwein; Noah D Peyser; Dong Xiao; Brenda Diergaarde; Lin Wang; Simion Chiosea; Raja Seethala; Jonas T Johnson; Seungwon Kim; Umamaheswar Duvvuri; Robert L Ferris; Marjorie Romkes; Tomoko Nukui; Patrick Kwok-Shing Ng; Levi A Garraway; Peter S Hammerman; Gordon B Mills; Jennifer R Grandis
Journal:  Cancer Discov       Date:  2013-04-25       Impact factor: 39.397

6.  A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.

Authors:  Harriet C Hafkamp; Ernst J M Speel; Annick Haesevoets; Fredrik J Bot; Winand N M Dinjens; Frans C S Ramaekers; Anton H N Hopman; Johannes J Manni
Journal:  Int J Cancer       Date:  2003-11-10       Impact factor: 7.396

7.  Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authors:  Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

8.  Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma.

Authors:  Matthias Lechner; Tim Fenton; James West; Gareth Wilson; Andrew Feber; Stephen Henderson; Christina Thirlwell; Harpreet K Dibra; Amrita Jay; Lee Butcher; Ankur R Chakravarthy; Fiona Gratrix; Nirali Patel; Francis Vaz; Paul O'Flynn; Nicholas Kalavrezos; Andrew E Teschendorff; Chris Boshoff; Stephan Beck
Journal:  Genome Med       Date:  2013-02-05       Impact factor: 11.117

9.  Integrated virus-host methylome analysis in head and neck squamous cell carcinoma.

Authors:  Gareth A Wilson; Matthias Lechner; Anna Köferle; Helena Caren; Lee M Butcher; Andrew Feber; Tim Fenton; Amrita Jay; Chris Boshoff; Stephan Beck
Journal:  Epigenetics       Date:  2013-07-18       Impact factor: 4.528

10.  The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.

Authors:  Agnieszka K Grabowska; Angelika B Riemer
Journal:  Open Virol J       Date:  2012-12-28
View more
  146 in total

Review 1.  [The epigenome. Target for innovative therapies in head and neck carcinoma].

Authors:  A Leipold; J Hess; K Zaoui
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

Review 2.  Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy.

Authors:  Joshua D Horton; Hannah M Knochelmann; Terry A Day; Chrystal M Paulos; David M Neskey
Journal:  Trends Cancer       Date:  2019-03-20

Review 3.  Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.

Authors:  Farhoud Faraji; Munfarid Zaidi; Carole Fakhry; Daria A Gaykalova
Journal:  Microbes Infect       Date:  2017-06-12       Impact factor: 2.700

4.  Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma.

Authors:  Theresa Guo; Kristina Diana A Zambo; Fernando T Zamuner; Tingting Ou; Christopher Hopkins; Dylan Z Kelley; Hildegard A Wulf; Eli Winkler; Rossin Erbe; Ludmila Danilova; Michael Considine; David Sidransky; Alexander Favorov; Liliana Florea; Elana J Fertig; Daria A Gaykalova
Journal:  Epigenetics       Date:  2020-03-22       Impact factor: 4.528

Review 5.  Cancer whole-genome sequencing: present and future.

Authors:  H Nakagawa; C P Wardell; M Furuta; H Taniguchi; A Fujimoto
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

6.  SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.

Authors:  Hiroyuki Ozawa; Ruchira S Ranaweera; Evgeny Izumchenko; Eugene Makarev; Alex Zhavoronkov; Elana J Fertig; Jason D Howard; Ana Markovic; Atul Bedi; Rajani Ravi; Jimena Perez; Quynh-Thu Le; Christina S Kong; Richard C Jordan; Hao Wang; Hyunseok Kang; Harry Quon; David Sidransky; Christine H Chung
Journal:  Clin Cancer Res       Date:  2017-05-18       Impact factor: 12.531

7.  Identification and characterization of an alternative cancer-derived PD-L1 splice variant.

Authors:  Nadia B Hassounah; Venkat S Malladi; Yi Huang; Samuel S Freeman; Ellen M Beauchamp; Shohei Koyama; Nicholas Souders; Sunil Martin; Glenn Dranoff; Kwok-Kin Wong; Chandra S Pedamallu; Peter S Hammerman; Esra A Akbay
Journal:  Cancer Immunol Immunother       Date:  2018-12-18       Impact factor: 6.968

Review 8.  Therapeutic Implications of the Genetic Landscape of Head and Neck Cancer.

Authors:  Janice Cho; Daniel E Johnson; Jennifer R Grandis
Journal:  Semin Radiat Oncol       Date:  2018-01       Impact factor: 5.934

Review 9.  Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives.

Authors:  Simonetta Ausoni; Paolo Boscolo-Rizzo; Bhuvanesh Singh; Maria Cristina Da Mosto; Giacomo Spinato; Giancarlo Tirelli; Roberto Spinato; Giuseppe Azzarello
Journal:  Cancer Metastasis Rev       Date:  2016-09       Impact factor: 9.264

Review 10.  Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.

Authors:  Peter S Hammerman; D Neil Hayes; Jennifer R Grandis
Journal:  Cancer Discov       Date:  2015-02-02       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.